Get started
Author

Paolo Scivetti

Observed name: P. Scivetti
ORCID: 0000-0001-6088-0095
Observed ORCID: 0000-0001-6088-0095
OpenAlex ID: A5070170987
Flow cytometric DNA index in the prognosis of colorectal cancer
1991 · Walter Giaretti, Marco Danova, et al. · Cancer · 69
PDF
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
2024 · Antonio De Vincentis, Javier Ampuero, et al. · Clinical Gastroenterology and Hepatology · 13
PDF
Prognostic parameters in myelodysplastic syndromes: A multiple regression analysis
1988 · Alberto Riccardi, Monica Giordano, et al. · European Journal Of Haematology · 13
Prognostic significance of DNA content in large bowel carcinoma: a retrospective flow cytrometric study
1989 · P. Scivetti, M. Danova, et al. · Cancer Letters · 11
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world
2025 · Francesca Terracciani, Antonio De Vincentis, et al. · JHEP Reports · 10
PDF
Postremission chemotherapy in adult acute non-lymphoblastic leukaemia including intensive or non-intensive consolidation therapy
1991 · Monica Giordano, Alberto Riccardi, et al. · European Journal of Cancer and Clinical Oncology · 9
Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study
2023 · F. Terracciani, A. De Vincentis, et al. · Digestive and Liver Disease · 4
Diagnosis of hepatic steatosis and steatohepatitis in people with new-onset type 2 diabetes: a multidisciplinary approach
2024 · L. Barana, A. Nelva, et al. · Endocrine · 3
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
2024 · F. Terracciani, A. De Vincentis, et al. · Digestive and Liver Disease · 3
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients
2022 · Carlo Smirne, Roberto Carbone, et al. · Eurasian Journal of Medicine · 3
THU-272 Appraising improvement in prediction of clinical outcomes based on different response criteria and liver stiffness measurements in patients with primary biliary cholangitis treated with second-line therapies
2025 · Antonio de Vincentis, Francesca Terracciani, et al. · Journal of Hepatology · 2
Long-term real-world experience with obeticholic acid in primary biliary cholangitis: the Italian recapitulate study
2023 · Francesca Terracciani, Antonio De Vincentis, et al. · Journal of Hepatology · 2
THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid
2024 · Antonio De Vincentis, Francesca Terracciani, et al. · Journal of Hepatology
THU-032 “Ama il tuo Fegato” program: screening for hepatic fibrosis using liver stiffness measurement (LSM)
2024 · Paolo Scivetti, Martina Costanzo, et al. · Journal of Hepatology
LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort
2024 · Francesca Terracciani, Antonio De Vincentis, et al. · Journal of Hepatology
Biochemical response to obeticholic acid drives liver stiffness variation over time and the risk of liver-related events in patients with primary biliary cholangitis
2024 · A. De Vincentis, F. Terracciani, et al. · Digestive and Liver Disease
Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS)
2023 · Antonio De Vincentis, Francesca Terracciani, et al. · Journal of Hepatology
Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)
2023 · A. De Vincentis, F. Terracciani, et al. · Digestive and Liver Disease
Reorganizing and simplifying HCV diagnosis and treatment in special populations during COVID pandemic and beyond
2022 · Paolo Scivetti, Elisa Perfetti, et al. · Journal of Hepatology
Ploidia E Attivita' Proliferativa Nel Nevo Displastico E Nel Melanoma Maligno
1990 · Paolo Scivetti, G. Borroni, et al.
Works count: 20
Citation count: 142
H-index: 6
I10-index: 5
Year
Topic
Type